PDS Biotechnology Corp
PDSB· Nasdaq
Released Mar 18, 2021, before the open
10-K filed Mar 18, 2021, 77 days after period end · 0001140361-21-009142
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017 |
|---|---|---|---|---|
| Net Income | -$4.03M | -$4.18M | -$1.82M | -$13.91M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2020 · filed Mar 18, 2021 · 77 d after period end
1.6% from the close of Mar 15, 2021 to the close of Mar 19, 2021, the first after the release.